Navrogen Inc. and Tavotek Biotherapeutics Announce Strategic Collaboration
17 Aug 2021 //
PRNEWSWIRE
Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing
22 Mar 2021 //
PRNEWSWIRE
Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing
22 Mar 2021 //
PRNASIA
Tavotek inks research pact with Genmab to develop bispecific antibodies
27 May 2020 //
PHARMABIZ
 
			 
								

 Market Place
 Market Place Sourcing Support
 Sourcing Support
